448 related articles for article (PubMed ID: 24239065)
1. Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Lee CH; Lee YT; Kung CH; Ku WW; Kuo SC; Chen TL; Fung CP
J Microbiol Immunol Infect; 2015 Jun; 48(3):269-75. PubMed ID: 24239065
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.
Park YS; Yoo S; Seo MR; Kim JY; Cho YK; Pai H
Int J Antimicrob Agents; 2009 Jul; 34(1):38-43. PubMed ID: 19297134
[TBL] [Abstract][Full Text] [Related]
5. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Arpin C; Dubois V; Maugein J; Jullin J; Dutilh B; Brochet JP; Larribet G; Fischer I; Quentin C
J Clin Microbiol; 2005 Oct; 43(10):5048-54. PubMed ID: 16207960
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
[TBL] [Abstract][Full Text] [Related]
8. Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.
Kanamori H; Navarro RB; Yano H; Sombrero LT; Capeding MR; Lupisan SP; Olveda RM; Arai K; Kunishima H; Hirakata Y; Kaku M
Acta Trop; 2011; 120(1-2):140-5. PubMed ID: 21820398
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
Wu YH; Chen PL; Hung YP; Ko WC
J Microbiol Immunol Infect; 2014 Jun; 47(3):197-203. PubMed ID: 23063776
[TBL] [Abstract][Full Text] [Related]
10. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
[TBL] [Abstract][Full Text] [Related]
11. Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae.
Brolund A; Wisell KT; Edquist PJ; Elfström L; Walder M; Giske CG
J Microbiol Methods; 2010 Sep; 82(3):229-33. PubMed ID: 20600365
[TBL] [Abstract][Full Text] [Related]
12. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.
Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt.
Mohamed ES; Khairy RMM; Abdelrahim SS
Antimicrob Resist Infect Control; 2020 Dec; 9(1):198. PubMed ID: 33303028
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing Enterobacteriaceae.
Gude MJ; Seral C; Sáenz Y; Cebollada R; González-Domínguez M; Torres C; Castillo FJ
Int J Med Microbiol; 2013 Dec; 303(8):553-7. PubMed ID: 23999104
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
Karkaba A; Grinberg A; Benschop J; Pleydell E
N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka.
Perera PDVM; Gamage S; De Silva HSM; Jayatilleke SK; de Silva N; Aydin A; Enne VI; Corea EM
J Glob Antimicrob Resist; 2022 Sep; 30():115-122. PubMed ID: 35667644
[TBL] [Abstract][Full Text] [Related]
18. Microbiological screening is necessary to distinguish carriers of plasmid-mediated AmpC beta-lactamase-producing enterobacteriaceae and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae because of clinical similarity.
Conen A; Frei R; Adler H; Dangel M; Fux CA; Widmer AF
PLoS One; 2015; 10(3):e0120688. PubMed ID: 25803720
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
Calbo E; Romaní V; Xercavins M; Gómez L; Vidal CG; Quintana S; Vila J; Garau J
J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
[TBL] [Abstract][Full Text] [Related]
20. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
